UPDATE 1-EU regulator promises speedy review of potential COVID-19 drug remdesivir
May 29, 2020 at 07:34 AM EDT
The European health regulator has vowed to conduct a speedy review of Gilead Sciences' potential COVID-19 drug, remdesivir, but said it has not yet received an application from the U.S. drugmaker.
